مورد إلكتروني

Immunotherapeutic strategies in antiphospholipid syndrome.

التفاصيل البيبلوغرافية
العنوان: Immunotherapeutic strategies in antiphospholipid syndrome.
بيانات النشر: Blackwell Publishing (E-mail: info@asia.blackpublishing.com.au) Australia 2017-03-11
تفاصيل مُضافة: Ross L.
Buchanan R.R.C.
Day J.
Hoi A.Y.
نوع الوثيقة: Electronic Resource
مستخلص: Antiphospholipid syndrome is an autoimmune condition, characterised by the persistent presence of antiphospholipid antibodies and either thrombosis or obstetric morbidity. The cornerstone of therapy is long-term anticoagulation to reduce morbidity and mortality; however, better understanding of the immunological pathways may direct us to develop future therapeutic strategies. We provide an overview of the current understanding of the immunopathogenesis of this perplexing condition and its associated morbidities and current evidence for some of the immunotherapeutic strategies.Copyright © 2017 Royal Australasian College of Physicians
مصطلحات الفهرس: complement factor H/ec [Endogenous Compound], eculizumab/dt [Drug Therapy], heparin/dt [Drug Therapy], hydroxychloroquine/dt [Drug Therapy], lipocortin 5/ec [Endogenous Compound], low molecular weight heparin/dt [Drug Therapy], phosphatidylinositol 3 kinase/ec [Endogenous Compound], rituximab/dt [Drug Therapy], plasmapheresis, anticoagulant therapy, antiphospholipid syndrome/dt [Drug Therapy], antiphospholipid syndrome/et [Etiology], antiphospholipid syndrome/th [Therapy], complement activation, complement deposition, conformational transition, human, immunopathogenesis, immunosuppressive treatment, immunotherapy, priority journal, review, syncytiotrophoblast, complement component C5a/ec [Endogenous Compound], Review
URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38810Test
Internal Medicine Journal
Click here for full text options
LibKey Link
الإتاحة: Open access content. Open access content
Copyright 2017 Elsevier B.V., All rights reserved.
أرقام أخرى: AUSHL oai:repository.monashhealth.org:1/38810
Internal Medicine Journal. 47 (3) (pp 250-256), 2017. Date of Publication: 01 Mar 2017.
1444-0903
https://repository.monashhealth.org/monashhealthjspui/handle/1/38810Test
27572264 [http://www.ncbi.nlm.nih.gov/pubmed/?term=27572264Test]
614679148
(Hoi, Ross, Day, Buchanan) Department of Rheumatology, Austin Health, Melbourne, VIC, Australia (Hoi) Department of Rheumatology, Monash Health, Melbourne, VIC, Australia (Hoi) School of Clinical Sciences, Monash University, Melbourne, VIC, Australia
Hoi A.Y.; alberta.hoi@austin.org.au
1305109948
المصدر المساهم: MONASH HEALTH LIBRS
From OAIster®, provided by the OCLC Cooperative.
رقم الانضمام: edsoai.on1305109948
قاعدة البيانات: OAIster